Status:
COMPLETED
Maternal High Blood Pressure and Newborn's Blood Profile
Lead Sponsor:
Romanian Society of Anesthesia and Intensive Care
Collaborating Sponsors:
University of Medicine and Pharmacy "Victor Babes" Timisoara
Timişoara County Emergency Clinical Hospital
Conditions:
Maternal-Fetal Exchange
Eligibility:
All Genders
1-28 years
Brief Summary
Maternal high blood pressure remodels the intrauterine environment of the fetus by altering hormonal and cellular signaling patterns and, as a result increases the risk of fetal and neonatal mortality...
Detailed Description
Pregnancy induced hypertension (PIH) and preeclampsia (preE) are caused by gestation and have an onset after 20 weeks of pregnancy. Although the exact etiology of PIH and preE remains unknown, two int...
Eligibility Criteria
Inclusion
- Age: 0-28 days
- Newborns of healthy mothers;
- Newborns of mothers with Pregnancy Induced Hypertension;
- Inborn Patients;
- Written Informed Consent signed by legal guardian.
Exclusion
- Maternal disease other than PIH;
- Syndromal, chromosomal or infectious diseases of the newborns;
- Causes other then PIH for perinatal asphyxia.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 25 2017
Estimated Enrollment :
6108 Patients enrolled
Trial Details
Trial ID
NCT03265704
Start Date
January 1 2016
End Date
August 25 2017
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Romanian Society of Anesthesia and Intensive Care
Timișoara, Romania